CTVA Corteva, Inc.
Agricultural Production-Crops · NYSE · SEC CIK 1755672 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY1.0%
TTM net income YoY-52.7%
TTM EPS YoY-51.3%
Revenue 3-yr CAGR0.6%
Net income 3-yr CAGR-6.6%
Margins
Gross margin49.7%
Operating margin—
Net margin4.3%
FCF margin-0.8%
EBITDA margin—
Returns
ROE3.1%
ROA1.8%
ROIC (approx.)—
Asset turnover0.41x
Leverage & solvency
Liabilities / assets42.5%
Debt / equity0.30x
Current ratio1.56x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.56x
Accruals ratio0.8%
Payout ratio63.5%
Capex / revenue3.3%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $17.40B | $16.91B | $17.23B | $17.45B | $15.65B |
| Cost of revenue | $9.17B | $9.53B | $9.92B | $10.44B | $9.22B |
| Gross profit | $8.23B | $7.38B | $7.31B | $7.02B | $6.43B |
| R&D expense | $1.47B | $1.40B | $1.34B | $1.22B | $1.19B |
| SG&A expense | $3.49B | $3.20B | $3.18B | $3.17B | $3.21B |
| Interest expense | $180.00M | $233.00M | $233.00M | $79.00M | $30.00M |
| Pretax income | $1.69B | $1.27B | $1.09B | $1.43B | $2.35B |
| Income tax | $484.00M | $412.00M | $152.00M | $210.00M | $524.00M |
| Net income | $1.09B | $907.00M | $735.00M | $1.15B | $1.76B |
| EPS (basic) | 1.60 | 1.31 | 1.04 | 1.59 | 2.39 |
| EPS (diluted) | 1.60 | 1.30 | 1.03 | 1.58 | 2.37 |
| Dividends declared per share | 0.70 | 0.66 | 0.62 | 0.58 | 0.52 |
| Weighted avg. shares (diluted) | 681.40M | 696.00M | 711.90M | 724.50M | 741.60M |
| Balance sheet | |||||
| Cash & equivalents | $4.52B | $3.11B | $2.64B | $3.19B | $4.46B |
| Short-term investments | $9.00M | $63.00M | $98.00M | $124.00M | $86.00M |
| Receivables | $4.88B | $4.45B | $4.21B | $4.17B | $3.44B |
| Inventory | $5.67B | $5.43B | $6.90B | $6.81B | $5.18B |
| Current assets | $17.34B | $15.10B | $16.26B | $16.80B | $15.55B |
| PP&E, net | $4.22B | $4.10B | $4.29B | $4.25B | $4.33B |
| Goodwill | $10.46B | $10.41B | $10.61B | $9.96B | $10.11B |
| Intangibles | $8.30B | $8.88B | $9.63B | $9.34B | $10.04B |
| Total assets | $42.84B | $40.83B | $43.00B | $42.62B | $42.34B |
| Current liabilities | $12.12B | $10.39B | $10.41B | $10.74B | $9.56B |
| Short-term debt | $894.00M | $750.00M | $198.00M | $24.00M | $17.00M |
| Long-term debt | $1.69B | $1.95B | $2.29B | $1.28B | $1.10B |
| Total debt | $2.58B | $2.70B | $2.49B | $1.31B | $1.12B |
| Total liabilities | $18.46B | $16.80B | $17.72B | $17.08B | $16.72B |
| Shareholders' equity | $24.14B | $23.79B | $25.04B | $25.30B | $25.38B |
| Net debt | -$1.94B | -$403.00M | -$155.00M | -$1.88B | -$3.34B |
| Shares outstanding | 672.16M | 685.60M | 701.26M | 713.42M | 726.53M |
| Cash flow statement | |||||
| Operating cash flow | $3.41B | $2.15B | $1.77B | $872.00M | $2.73B |
| Capital expenditure | $591.00M | $597.00M | $595.00M | $605.00M | $573.00M |
| Free cash flow | $2.81B | $1.55B | $1.17B | $267.00M | $2.15B |
| Investing cash flow | -$543.00M | -$589.00M | -$1.99B | -$632.00M | -$362.00M |
| Financing cash flow | -$1.64B | -$1.20B | -$99.00M | -$1.18B | -$1.27B |
| Depreciation & amortization | $1.20B | $1.23B | $1.21B | $1.22B | $1.24B |
| Dividends paid | $475.00M | $458.00M | $439.00M | $418.00M | $397.00M |
| Share buybacks | $1.07B | $1.01B | $756.00M | $1.00B | $950.00M |
Free plan shows the latest 5 periods; Pro shows all 8 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.